Transplant Molecular Rejection Classification Market

Acute rejection classification leads the application category with 38.0% share, while molecular microscope diagnostic system holds 37.1% of the test type category. Transplant centers lead end users with 36.4% share, reflecting their role in molecular testing and treatment decisions.